RT Journal Article
SR Electronic
T1 Personalizing dietary interventions by predicting individual vulnerability to glucose excursions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.07.24311591
DO 10.1101/2024.08.07.24311591
A1 Brügger, Victoria
A1 Kowatsch, Tobias
A1 Jovanova, Mia
YR 2024
UL http://medrxiv.org/content/early/2024/08/07/2024.08.07.24311591.abstract
AB Elevated postprandial glucose levels pose a global epidemic and are crucial in cardiometabolic disease management and prevention. A major challenge is inter-individual variability, which limits the effectiveness of population-wide dietary interventions. To develop personalized interventions, it is critical to first predict a person’s vulnerability to postprandial glucose excursions—or elevated post-meal glucose relative to a personal baseline—with minimal burden. We examined the feasibility of personalized models to predict future glucose excursions in the daily lives of 69 Chinese adults with type-2 diabetes (M age=61.5; 50% women; 2’595 glucose observations). We developed machine learning models, trained on past individual context and meal-based observations, employing low-burden (continuous glucose monitoring) or additional high-burden (manual meal tracking) approaches. Personalized models predicted glucose excursions (F1-score: M=74%; median=78%), with some individuals being more predictable than others. The low burden-models performed better for those with consistent meal patterns and healthier glycemic profiles. Notably, no two individuals shared the same meal and context-based vulnerability predictors. This study is the first to predict individual vulnerability to glucose excursions among a sample of Chinese adults with type-2 diabetes. Findings can help personalize just-in-time-adaptive dietary interventions to unique vulnerability to glucose excursions in daily live, thereby helping improve diabetes management.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at: https://figshare.com/collections/Diabetes_Datasets_ShanghaiT1DM_and_ShanghaiT2DM/6310860/2